Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc.（AVTE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
avte · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年2月3日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Hold
8 位分析师
共识
评级分布
12 个月目标价
High
$35.00
Consensus
$13.00
-86.1% upside
Low
$2.00
Median: $2 · Last Close: $93.80
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$13.00
-86.1% upside
High Target
$35
-62.7%
Low Target
$2
-97.9%
Current Price
$93.80
as of today
Based on analyst price targets, the AVTE stock price prediction for the next 12 months ranges from $2 to $35. The consensus AVTE price forecast of $13.00 implies -86.1% upside from the current price of $93.80.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $95.58 | ↑ 1.89% |
1-day model range: $95–$96.15. Peak: $96.15 (+1.89%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AVTE · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-06-18 | Evercore ISI Group | Downgrade ↓ | Outperform→In Line |
| 2024-06-18 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-06-18 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2024-06-18 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2024-06-17 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2024-06-17 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2024-06-06 | Wedbush | Maintains | Outperform→Outperform |
| 2024-05-22 | Wedbush | Maintains | Outperform→Outperform |
| 2024-05-14 | Wedbush | Maintains | Outperform→Outperform |
| 2024-04-01 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Aerovate Therapeutics, Inc. (AVTE) stock. Of the recent 20 rating actions, 2 were upgrades and 8 were downgrades. 8 analysts currently cover AVTE.
分析师推荐趋势
AVTE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$20M
EPS This Year
$-0.65
EPS Next Year
$-0.79
↑ 21.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AVTE EPS of $-0.65 for the current fiscal year, based on estimates from 2 analysts. The AVTE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AVTE 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AVTE 的共识目标价为 $13.00（-86.1% 上行空间），分析师共识为 Hold。
AVTE 的短期预测（明日）为 $95.58（+1.89%）。
Aerovate Therapeutics, Inc. 在 NASDAQ 上市，代码 AVTE。AVTE 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 25% 对应 Hold 共识。
常见问题
AVTE 预测 · 8 个问题根据 8 位华尔街分析师，AVTE 的 12 个月平均目标价为 $13.00，最高 $35.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $93.80，隐含约 -86.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.